BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND MSN, P26038, 4478, ENSG00000147065 AND Treatment
9 results:

  • 1. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
    Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
    Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy.
    Saroj S; Rajput SJ
    Drug Dev Ind Pharm; 2019 Apr; 45(4):532-547. PubMed ID: 30582382
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
    Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
    Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
    Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
    Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Farolfi A; Ceci F; Castellucci P; Graziani T; Siepe G; Lambertini A; Schiavina R; Lodi F; Morganti AG; Fanti S
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):11-19. PubMed ID: 29905907
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of external beam radiotherapy versus permanent seed brachytherapy as monotherapy for intermediate-risk prostate cancer - a single center Canadian experience.
    Delouya G; Lambert C; Bahary JP; Beauchemin MC; Barkati M; Ménard C; Taussky D
    Can J Urol; 2017 Jun; 24(3):8822-8826. PubMed ID: 28646937
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Asymptotic dynamics of some t-periodic one-dimensional model with application to prostate cancer immunotherapy.
    Foryś U; Bodnar M; Kogan Y
    J Math Biol; 2016 Oct; 73(4):867-83. PubMed ID: 26897354
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A comparative analysis of prostate cancer pre-treatment characteristics stratified by age.
    Shah N; Ioffe V; Kapur A
    Can J Urol; 2014 Apr; 21(2):7213-6. PubMed ID: 24775574
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Can people find patient decision aids on the Internet?
    Morris D; Drake E; Saarimaki A; Bennett C; O'Connor A
    Patient Educ Couns; 2008 Dec; 73(3):557-60. PubMed ID: 18789628
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.